Voyager Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of VYGR for the last quarter is 24.63 M USD, and it's 16.73% lower compared to the previous quarter. The net income of Q3 24 is -9.04 M USD.